Triple therapy with low-dose dapagliflozin plus saxagliptin versus dual therapy with each monocomponent, all added to metformin, in uncontrolled type 2 diabetes
| Image |  |
|---|---|
| Description | scientific article published on 24 June 2019 |
| Author/s |
author: Julio Rosenstock |
| Publication date | June 24, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |